Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China · Delayed Price · Currency is CNY 47.76
+1.84 (4.01%)
At close: Feb 6, 2026
SHA:600329 Market Cap
SHA:600329 has a market cap or net worth of 31.9 billion as of February 6, 2026. Its market cap has increased by 62.59% in one year.
Market Cap
31.90B
Enterprise Value
30.21B
Revenue
5.37B
Ranking
n/a
PE Ratio
10.25
Stock Price
47.76
Market Cap Chart
Since June 6, 2001, SHA:600329's market cap has increased from 6.92B to 31.90B, an increase of 361.36%. That is a compound annual growth rate of 6.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 31.90B | 3.66% |
| Dec 31, 2025 | 30.78B | 48.69% |
| Dec 31, 2024 | 20.70B | -6.43% |
| Dec 29, 2023 | 22.12B | 21.24% |
| Dec 30, 2022 | 18.25B | -6.30% |
| Dec 31, 2021 | 19.47B | 73.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Changchun High-Tech Industry (Group) | 36.37B |
| Dong-E-E-Jiao | 34.93B |
| Humanwell Healthcare (Group) | 31.47B |
| Shijiazhuang Yiling Pharmaceutical | 30.21B |
| Livzon Pharmaceutical Group | 28.66B |
| Chengdu Kanghong Pharmaceutical Group | 26.81B |
| Kangmei Pharmaceutical | 26.55B |
| Hubei Jumpcan Pharmaceutical | 25.01B |